CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Tickers
- INDV SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Securities
- INDV Common stock Nasdaq
- SUPN Common Stock Nasdaq
- Open-market buys, last 90 days
- $53,535
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$53,535. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Preblick Ryan Chief Financial Officer | Sale 10b5-1 | −36,000 | $37.70 | $1.4M | 284,751 |
| 2026-03-14 | Preblick Ryan Chief Financial Officer | Option exercise | +6,302 | 323,594 | ||
| 2026-03-14 | Preblick Ryan Chief Financial Officer | Shares withheld for taxes | −2,843 | $31.11 | $88K | 320,751 |
| 2026-03-14 | Preblick Ryan Chief Financial Officer | Option exercise · Restricted Stock Units | −6,302 | 0 | ||
| 2026-03-03 | Preblick Ryan Chief Financial Officer | Shares withheld for taxes | −87,597 | $31.98 | $2.8M | 230,343 |
| 2026-03-03 | Preblick Ryan Chief Financial Officer | Option exercise | +86,949 | 317,292 | ||
| 2026-03-03 | Preblick Ryan Chief Financial Officer | Option exercise · Performance Stock Units | −113,510 | 0 | ||
| 2026-02-10 | Preblick Ryan Chief Financial Officer | Grant or award | +37,358 | 317,940 | ||
| 2026-02-09 | Preblick Ryan Chief Financial Officer | Grant or award · Performance Stock Units | +113,510 | 113,510 |
Page 1 of 1 · 9 trades